Drug Type Gene editing |
Synonyms- |
Target |
Mechanism RANGRF modulators(RAN guanine nucleotide release factor modulators) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Brugada Syndrome | Preclinical | US | 07 Jun 2022 |